- Stocks
- Healthcare
- NASDAQ: MGLN

Price (delayed)

$94.25

Market cap

$2.46B

P/E Ratio

6.09

Dividend/share

N/A

EPS

$15.48

Enterprise value

$2.54B

The stock's price to earnings (P/E) is 85% less than its 5-year quarterly average of 41.5 and 36% less than its last 4 quarters average of 9.5

Magellan Health's quick ratio has soared by 76% YoY and by 2.9% from the previous quarter

Magellan Health's gross profit has increased by 20% QoQ but it has decreased by 19% YoY

Magellan Health's gross margin has increased by 19% from the previous quarter but it has decreased by 18% YoY

What are the main financial stats of MGLN

Market
Valuations
Earnings

Shares outstanding

26.13M

Market cap

$2.46B

Enterprise value

$2.54B

Price to earnings (P/E)

6.09

Price to book (P/B)

1.28

Price to sales (P/S)

0.53

EV/EBIT

6.67

EV/EBITDA

5.16

EV/Sales

0.55

Revenue

$4.62B

EBIT

$380.86M

EBITDA

$492.34M

Free cash flow

$261.86M

Per share
Balance sheet
Liquidity

EPS

$15.48

Free cash flow per share

$10.08

Book value per share

$73.54

Revenue per share

$177.8

TBVPS

$88.23

Total assets

$3.24B

Total liabilities

$1.29B

Debt

$533.23M

Equity

$1.91B

Working capital

$1.36B

Debt to equity

0.28

Current ratio

3.06

Quick ratio

2.83

Net debt/EBITDA

0.16

Margins
Efficiency
Dividend

EBITDA margin

10.7%

Gross margin

3.1%

Net margin

8.5%

Operating margin

0.4%

Return on assets

11.8%

Return on equity

22.7%

Return on invested capital

22.6%

Return on capital employed

14.8%

Return on sales

8.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Magellan Health stock price performed over time

Intraday

-0.06%

1 week

-0.01%

1 month

-0.07%

1 year

39.55%

YTD

13.77%

QTD

1.08%

How have Magellan Health's revenue and profit performed over time

Revenue

$4.62B

Gross profit

$142.07M

Operating income

$19.39M

Net income

$391.91M

Gross margin

3.1%

Net margin

8.5%

Magellan Health's operating margin has plunged by 73% YoY

Magellan Health's operating income has shrunk by 71% YoY

Magellan Health's gross profit has increased by 20% QoQ but it has decreased by 19% YoY

Magellan Health's gross margin has increased by 19% from the previous quarter but it has decreased by 18% YoY

What is Magellan Health's growth rate over time

What is Magellan Health stock price valuation

P/E

6.09

P/B

1.28

P/S

0.53

EV/EBIT

6.67

EV/EBITDA

5.16

EV/Sales

0.55

The stock's price to earnings (P/E) is 85% less than its 5-year quarterly average of 41.5 and 36% less than its last 4 quarters average of 9.5

MGLN's EPS is up by 2.2% since the previous quarter

MGLN's equity is up by 33% year-on-year and by 2.1% since the previous quarter

The P/B is 9% less than the 5-year quarterly average of 1.4 but 7% more than the last 4 quarters average of 1.2

How efficient is Magellan Health business performance

MGLN's ROS has soared by 193% year-on-year

MGLN's return on invested capital has surged by 163% year-on-year but it is down by 2.2% since the previous quarter

The company's return on equity fell by 4.6% QoQ

MGLN's ROA is up by 2.6% since the previous quarter

What is MGLN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MGLN.

How did Magellan Health financials performed over time

The total assets is 150% more than the total liabilities

Magellan Health's quick ratio has soared by 76% YoY and by 2.9% from the previous quarter

Magellan Health's current ratio has soared by 75% YoY and by 4.8% from the previous quarter

Magellan Health's debt is 72% lower than its equity

MGLN's debt to equity is down by 45% YoY and by 18% QoQ

MGLN's equity is up by 33% year-on-year and by 2.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.